Nasdaq · CIK 0001381668
TFSL TFS Financial CORP
Insider trading from SEC Form 4. Last filing 28 d ago. Close $16.07 on Oct 9, 2026, +37% from the 52-week low and -12% from the high.
Last 90 days
Net insider value
-$727k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$727k by 5 insiders
Insiders on file
17
with a Form 4 at this company
Price and insider trades, last year
TFSLOct 9, 2026 · close 16.07
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at TFS Financial CORP, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Bradley T Stefanski Chief Strategy Officer sell | $169k 10,000 shares | -21% | +45% from low-7% from high | |
| 71Notable | Marc A Stefanski Chairman, President and CEO sell | $173k 10,000 shares | -27% | +45% from low-7% from high | |
| 51Moderate | Ashley H Williams director sell | $173k 10,000 shares | -27% | +45% from low-7% from high | |
| 47Moderate | Meredith S Weil Chief Financial Officer sell | $103k 5,861 shares | -13% | +46% from low-6% from high | |
| 60Notable | Barbara J. Anderson director sell | $109k 6,100 shares | -98% | +46% from low-6% from high | |
| 31Weak | Anthony J Asher director buy | $67k 5,000 shares | +11% | +26% from low-10% from high | |
| 45Moderate | Gavin B Stefanski Chief Experience Officer sell | $105k 7,000 shares | -21% | +38% from low-2% from high | |
| 79Notable | Marc A Stefanski Chairman, President and CEO sell | $572k 37,844 shares | -34% | +37% from low-1% from high | |
| 60Notable | Marc A Stefanski Chairman, President and CEO sell | $108k 7,156 shares | -7% | +37% from low-1% from high | |
| 64Notable | Meredith S Weil Chief Financial Officer sell | $224k 15,000 shares | -22% | +37% from low-1% from high | |
| 61Notable | Barbara J. Anderson director sell | $156k 11,000 shares | -64% | +32% from low-2% from high | |
| 15Weak | Anthony J Asher director buy | $20k 1,439 shares | +4% | +28% from low-2% from high | |
| 28Weak | Ashley H Williams director sell | $104k 7,600 shares | -32% | +26% from low-3% from high | |
| 54Moderate | Cathy W Zbanek Chief Synergy Officer sell | $283k 20,000 shares | -27% | +29% from low-1% from high | |
| 48Moderate | Andrew J Rubino Chief Operating Officer sell | $71k 5,000 shares | -21% | +28% from low0% from high | |
| 57Moderate | Meredith S Weil Chief Financial Officer sell | $208k 15,000 shares | -24% | +24% from low-1% from high | |
| 42Moderate | Daniel F Weir director sell | $52k 3,900 shares | -21% | +21% from low-3% from high | |
| 64Notable | Meredith S Weil Chief Financial Officer sell | $206k 15,000 shares | -19% | +20% from low-4% from high | |
| 80Strong | Marc A Stefanski Chairman, President and CEO sell | $102k 7,200 shares | -100% | +24% from low-1% from high | |
| 41Moderate | Anthony J Asher director buy | $500k 37,675 shares | - | +17% from low-3% from high | |
| 54Moderate | Barbara J. Anderson director sell | $157k 12,000 shares | -85% | +15% from low-4% from high | |
| 36Weak | Gavin B Stefanski Chief Experience Officer sell | $47k 3,505 shares | -10% | +15% from low-4% from high | |
| 47Moderate | Cathy W Zbanek Chief Synergy Officer sell | $202k 15,000 shares | -17% | +15% from low-4% from high | |
| 72Notable | Anthony J Asher director sell | $797k 59,507 shares | -100% | +16% from low-4% from high | |
| 64Notable | Meredith S Weil Chief Financial Officer sell | $202k 15,000 shares | -16% | +15% from low-4% from high | |
| 44Moderate | Andrew J Rubino Chief Information Officer sell | $82k 6,000 shares | -20% | +17% from low-3% from high | |
| 31Weak | Anthony J Asher director sell | $164k 13,500 shares | -18% | +2% from low-13% from high | |
| 35Weak | Barbara J. Anderson director sell | $21k 1,500 shares | -88% | - | |
| 18Weak | Daniel F Weir director buy | $14k 1,059 shares | +7% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 15, 2025 | BARBARA ANDERSON Director | 12,000 0.00% of outstanding | $157k | Aug 15, 2025 | none |
| May 12, 2025 | Stefanski Gavin B Officer | 3,505 0.00% of outstanding | $48k | May 12, 2025 | none |
| May 8, 2025 | Asher Anthony J Director | 59,507 0.02% of outstanding | $797k | May 8, 2025 | $164k |
| May 7, 2025 | Zbanek Cathy W Affiliate | 15,000 0.01% of outstanding | $202k | May 7, 2025 | none |
| May 6, 2025 | WEIL MEREDITH S Officer | 15,000 0.01% of outstanding | $203k | May 6, 2025 | $163k |
| May 5, 2025 | ANDREW RUBINO Officer | 6,000 0.00% of outstanding | $82k | May 5, 2025 | none |
| Mar 11, 2025 | Asher Anthony J Director | 13,500 0.00% of outstanding | $165k | Mar 11, 2025 | none |
| Feb 26, 2025 | Stefanski Marc A Officer | 150,000 0.05% of outstanding | $2.1M | Feb 26, 2025 | none |
| Feb 26, 2025 | Weir Daniel F Director | 10,000 0.00% of outstanding | $133k | Feb 26, 2025 | none |
| Feb 7, 2025 | Stefanski Gavin B Officer | 7,000 0.00% of outstanding | $96k | Feb 7, 2025 | none |
| Feb 7, 2025 | WEIL MEREDITH S Officer | 12,000 0.00% of outstanding | $165k | Feb 7, 2025 | none |
| Feb 5, 2025 | Zbanek Cathy W Officer | 20,000 0.01% of outstanding | $275k | Feb 5, 2025 | none |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Bradley T Stefanski Chief Strategy Officer | SOpen-market sale Common Stock | -10,000 | $16.94 | $169k | 38,720 | 28 d ago |
| Sep 8, 2026 | Marc A Stefanski Chairman, President and CEO | SOpen-market sale Common Stockindirect: Trustee for daughter's trust | -10,000 | $17.28 | $173k | 27,150 | 33 d ago |
| Sep 8, 2026 | Ashley H Williams director | SOpen-market sale Common Stockindirect: Trust Beneficiary | -10,000 | $17.28 | $173k | 27,150 | 33 d ago |
| Sep 3, 2026 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | +52,793 | $14.74 | $778k | 91,273 | 39 d ago |
| Sep 3, 2026 | Meredith S Weil Chief Financial Officer | FTax withholding Common Stock | -46,932 | $17.50 | $821k | 44,341 | 39 d ago |
| Sep 3, 2026 | Meredith S Weil Chief Financial Officer | SOpen-market sale Common Stock | -5,861 | $17.53 | $103k | 38,480 | 39 d ago |
| Sep 3, 2026 | Meredith S Weil Chief Financial Officer | MOption exercise Employee Stock Option (right to buy)derivative | -52,793 | $14.74 | $778k | 0 | 39 d ago |
| Aug 31, 2026 | Barbara J. Anderson director | SOpen-market sale Common Stock | -6,100 | $17.83 | $109k | 100 | 42 d ago |
| Mar 12, 2026 | Anthony J Asher director | POpen-market purchase Common Stockindirect: Trust Beneficiary | +5,000 | $13.37 | $67k | 49,314 | Mar 13, 2026 |
| Feb 20, 2026 | Gavin B Stefanski Chief Experience Officer | SOpen-market sale Common Stockindirect: In Trust | -7,000 | $14.97 | $105k | 25,766 | Feb 23, 2026 |
| Feb 13, 2026 | Marc A Stefanski Chairman, President and CEO | SOpen-market sale Common Stock | -1,000 | $15.00 | $15k | 108,841 | Feb 18, 2026 |
| Feb 17, 2026 | Marc A Stefanski Chairman, President and CEO | SOpen-market sale Common Stock | -36,844 | $15.12 | $557k | 71,997 | Feb 18, 2026 |
| Feb 12, 2026 | Marc A Stefanski Chairman, President and CEO | SOpen-market sale Common Stock | -7,149 | $15.03 | $107k | 109,848 | Feb 13, 2026 |
| Feb 11, 2026 | Marc A Stefanski Chairman, President and CEO | SOpen-market sale Common Stock | -7 | $15.00 | $105 | 109,841 | Feb 13, 2026 |
| Feb 11, 2026 | Meredith S Weil Chief Financial Officer | SOpen-market sale Common Stock | -12,911 | $14.95 | $193k | 54,325 | Feb 12, 2026 |
| Feb 11, 2026 | Meredith S Weil Chief Financial Officer | SOpen-market sale Common Stock | -2,089 | $14.95 | $31k | 52,236 | Feb 12, 2026 |
| Feb 3, 2026 | Barbara J. Anderson director | SOpen-market sale Common Stock | -11,000 | $14.21 | $156k | 6,200 | Feb 4, 2026 |
| Jan 8, 2026 | Anthony J Asher director | JOther Common Stock | -39,114 | $0.00 | $0 | 0 | Jan 9, 2026 |
| Jan 8, 2026 | Anthony J Asher director | JOther Common Stockindirect: By Spouse | -5,200 | $0.00 | $0 | 0 | Jan 9, 2026 |
| Jan 8, 2026 | Anthony J Asher director | JOther Common Stockindirect: Trust Beneficiary | +44,314 | $0.00 | $0 | 44,314 | Jan 9, 2026 |
| Dec 18, 2025 | Marc A Stefanski Chairman, President and CEO | AGrant or award Restricted Stock Unitsderivative | +215,200 | $0.00 | $0 | 215,200 | Dec 22, 2025 |
| Dec 18, 2025 | Robert A Fiala director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | William C Mulligan director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Terrence R Ozan director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Barbara J. Anderson director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Terrence L. Bauer director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Daniel F Weir director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Anthony J Asher director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | John Ringenbach director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Andrew J Rubino Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +14,300 | $0.00 | $0 | 14,300 | Dec 18, 2025 |
| Dec 18, 2025 | Cathy W Zbanek Chief Synergy Officer | AGrant or award Restricted Stock Unitsderivative | +15,800 | $0.00 | $0 | 15,800 | Dec 18, 2025 |
| Dec 18, 2025 | Ashley H Williams director | AGrant or award Restricted Stock Unitsderivative | +7,500 | $0.00 | $0 | 7,500 | Dec 18, 2025 |
| Dec 18, 2025 | Meredith S Weil Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +16,500 | $0.00 | $0 | 16,500 | Dec 18, 2025 |
| Dec 18, 2025 | Martin J Cohen director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Dec 18, 2025 |
| Dec 18, 2025 | Bradley T Stefanski Chief Strategy Officer | AGrant or award Restricted Stock Unitsderivative | +8,600 | $0.00 | $0 | 8,600 | Dec 18, 2025 |
| Dec 18, 2025 | Gavin B Stefanski Chief Experience Officer | AGrant or award Restricted Stock Unitsderivative | +8,600 | $0.00 | $0 | 8,600 | Dec 18, 2025 |
| Dec 18, 2025 | Marc A Stefanski Chairman, President and CEO | AGrant or award Restricted Stock Unitsderivative | +40,200 | $0.00 | $0 | 40,200 | Dec 18, 2025 |
| Dec 15, 2025 | Anthony J Asher director | POpen-market purchase Common Stock | +1,439 | $13.89 | $20k | 39,114 | Dec 16, 2025 |
| Dec 15, 2025 | Marc A Stefanski Chairman, President and CEO | GGift Common Stock | -3,500 | $0.00 | $0 | 136,997 | Dec 16, 2025 |
| Dec 15, 2025 | Marc A Stefanski Chairman, President and CEO | GGift Common Stock | -20,000 | $0.00 | $0 | 116,997 | Dec 16, 2025 |
| Dec 15, 2025 | Marc A Stefanski Chairman, President and CEO | GGift Common Stockindirect: By Spouse | +3,500 | $0.00 | $0 | 28,200 | Dec 16, 2025 |
| Dec 12, 2025 | Anthony J Asher director | GGift Common Stock | -5,100 | $0.00 | $0 | 37,675 | Dec 15, 2025 |
| Dec 12, 2025 | Anthony J Asher director | GGift Common Stockindirect: By Spouse | +5,100 | $0.00 | $0 | 5,200 | Dec 15, 2025 |
| Dec 10, 2025 | Terrence R Ozan director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 91,000 | Dec 12, 2025 |
| Dec 10, 2025 | John Ringenbach director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 34,600 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | MOption exercise Common Stock | +8,730 | $0.00 | $0 | 27,856 | Dec 12, 2025 |
| Dec 10, 2025 | Daniel F Weir director | MOption exercise Common Stock | +10,000 | $0.00 | $0 | 24,943 | Dec 12, 2025 |
| Dec 10, 2025 | Cathy W Zbanek Chief Synergy Officer | MOption exercise Common Stock | +18,990 | $0.00 | $0 | 72,187 | Dec 12, 2025 |
| Dec 10, 2025 | Bradley T Stefanski Chief Strategy Officer | MOption exercise Common Stock | +1,433 | $0.00 | $0 | 49,392 | Dec 12, 2025 |
| Dec 10, 2025 | Gavin B Stefanski Chief Experience Officer | MOption exercise Common Stock | +1,433 | $0.00 | $0 | 1,433 | Dec 12, 2025 |
| Dec 10, 2025 | Marc A Stefanski Chairman, President and CEO | MOption exercise Common Stock | +36,180 | $0.00 | $0 | 129,609 | Dec 12, 2025 |
| Dec 10, 2025 | Barbara J. Anderson director | MOption exercise Common Stock | +10,000 | $0.00 | $0 | 12,100 | Dec 12, 2025 |
| Dec 10, 2025 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | +19,170 | $0.00 | $0 | 67,697 | Dec 12, 2025 |
| Dec 10, 2025 | Anthony J Asher director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 42,775 | Dec 12, 2025 |
| Dec 10, 2025 | Terrence L. Bauer director | MOption exercise Common Stock | +7,220 | $0.00 | $0 | 7,220 | Dec 12, 2025 |
| Dec 10, 2025 | Martin J Cohen director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 42,500 | Dec 12, 2025 |
| Dec 10, 2025 | Robert A Fiala director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 75,900 | Dec 12, 2025 |
| Dec 10, 2025 | William C Mulligan director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 68,900 | Dec 12, 2025 |
| Dec 10, 2025 | Timothy W Mulhern Chief Innovation Officer | MOption exercise Common Stock | +8,730 | $0.00 | $0 | 23,143 | Dec 12, 2025 |
| Dec 10, 2025 | Ashley H Williams director | MOption exercise Common Stock | +7,600 | $0.00 | $0 | 24,110 | Dec 12, 2025 |
| Dec 10, 2025 | Terrence R Ozan director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | MOption exercise Common Stock | +2,134 | $0.00 | $0 | 29,990 | Dec 12, 2025 |
| Dec 10, 2025 | Daniel F Weir director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 30,043 | Dec 12, 2025 |
| Dec 10, 2025 | Cathy W Zbanek Chief Synergy Officer | MOption exercise Common Stock | +4,667 | $0.00 | $0 | 76,854 | Dec 12, 2025 |
| Dec 10, 2025 | Bradley T Stefanski Chief Strategy Officer | FTax withholding Common Stock | -672 | $13.91 | $9,348 | 48,720 | Dec 12, 2025 |
| Dec 10, 2025 | Gavin B Stefanski Chief Experience Officer | FTax withholding Common Stock | -658 | $13.91 | $9,153 | 775 | Dec 12, 2025 |
| Dec 10, 2025 | Marc A Stefanski Chairman, President and CEO | MOption exercise Common Stock | +13,400 | $0.00 | $0 | 143,009 | Dec 12, 2025 |
| Dec 12, 2025 | Ashley H Williams director | SOpen-market sale Common Stock | -7,600 | $13.66 | $104k | 16,510 | Dec 12, 2025 |
| Dec 10, 2025 | Barbara J. Anderson director | MOption exercise Common Stock | +5,100 | $0.00 | $0 | 17,200 | Dec 12, 2025 |
| Dec 10, 2025 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | +4,734 | $0.00 | $0 | 72,431 | Dec 12, 2025 |
| Dec 10, 2025 | Terrence L. Bauer director | MOption exercise Restricted Stock Unitsderivative | -7,220 | $0.00 | $0 | 28,880 | Dec 12, 2025 |
| Dec 10, 2025 | Robert A Fiala director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | William C Mulligan director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Timothy W Mulhern Chief Innovation Officer | MOption exercise Common Stock | +2,167 | $0.00 | $0 | 25,310 | Dec 12, 2025 |
| Dec 10, 2025 | Cathy W Zbanek Chief Synergy Officer | MOption exercise Common Stock | +4,733 | $0.00 | $0 | 81,587 | Dec 12, 2025 |
| Dec 10, 2025 | John Ringenbach director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | MOption exercise Common Stock | +2,167 | $0.00 | $0 | 32,157 | Dec 12, 2025 |
| Dec 10, 2025 | Anthony J Asher director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Marc A Stefanski Chairman, President and CEO | MOption exercise Common Stock | +13,567 | $0.00 | $0 | 156,576 | Dec 12, 2025 |
| Dec 10, 2025 | Barbara J. Anderson director | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | Dec 12, 2025 |
| Dec 10, 2025 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | +4,800 | $0.00 | $0 | 77,231 | Dec 12, 2025 |
| Dec 10, 2025 | Timothy W Mulhern Chief Innovation Officer | MOption exercise Common Stock | +2,134 | $0.00 | $0 | 27,444 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | MOption exercise Common Stock | +2,900 | $0.00 | $0 | 35,057 | Dec 12, 2025 |
| Dec 10, 2025 | Daniel F Weir director | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 20,000 | Dec 12, 2025 |
| Dec 10, 2025 | Marc A Stefanski Chairman, President and CEO | MOption exercise Common Stock | +13,466 | $0.00 | $0 | 170,042 | Dec 12, 2025 |
| Dec 10, 2025 | Barbara J. Anderson director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | +5,533 | $0.00 | $0 | 82,764 | Dec 12, 2025 |
| Dec 10, 2025 | Cathy W Zbanek Chief Synergy Officer | MOption exercise Common Stock | +5,300 | $0.00 | $0 | 86,887 | Dec 12, 2025 |
| Dec 10, 2025 | Martin J Cohen director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Timothy W Mulhern Chief Innovation Officer | FTax withholding Common Stock | -8,908 | $13.91 | $124k | 18,536 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | FTax withholding Common Stock | -7,147 | $13.91 | $99k | 27,910 | Dec 12, 2025 |
| Dec 10, 2025 | Bradley T Stefanski Chief Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -1,433 | $0.00 | $0 | 2,867 | Dec 12, 2025 |
| Dec 10, 2025 | Gavin B Stefanski Chief Experience Officer | MOption exercise Restricted Stock Unitsderivative | -1,433 | $0.00 | $0 | 2,867 | Dec 12, 2025 |
| Dec 10, 2025 | Marc A Stefanski Chairman, President and CEO | FTax withholding Common Stock | -29,545 | $13.91 | $411k | 140,497 | Dec 12, 2025 |
| Dec 10, 2025 | Daniel F Weir director | MOption exercise Restricted Stock Unitsderivative | -5,100 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Ashley H Williams director | MOption exercise Restricted Stock Unitsderivative | -7,600 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Cathy W Zbanek Chief Synergy Officer | FTax withholding Common Stock | -15,786 | $13.91 | $220k | 71,101 | Dec 12, 2025 |
| Dec 10, 2025 | Meredith S Weil Chief Financial Officer | MOption exercise Common Stock | -15,528 | $13.91 | $216k | 67,236 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew J Rubino Chief Operating Officer | MOption exercise Performance Restricted Share Unitsderivative | -8,730 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | Timothy W Mulhern Chief Innovation Officer | MOption exercise Performance Restricted Share Unitsderivative | -8,730 | $0.00 | $0 | 0 | Dec 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Barbara J. Andersondirector
- Anthony J Asherdirector
- Terrence L. Bauerdirector
- Martin J Cohendirector
- Robert A Fialadirector
- William C Mulligandirector
- Timothy W MulhernChief Innovation Officer
- Terrence R Ozandirector
- John Ringenbachdirector
- Andrew J RubinoChief Operating Officer
- Bradley T StefanskiChief Strategy Officer
- Gavin B StefanskiChief Experience Officer
- Marc A StefanskiChairman, President and CEO
- Meredith S WeilChief Financial Officer
- Daniel F Weirdirector
- Ashley H Williamsdirector
- Cathy W ZbanekChief Synergy Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.